A 30-year-old Bangladeshi male presented to an ear, nose and throat surgeon with a 4-year history of chronic discharge from the right ear. He was first diagnosed with a cholesteatoma in Bangladesh in 2000 and underwent three operative procedures for clearance of the cholesteatoma and removal of mastoid air cells. However, chronic discharge from the ear continued. In 2004 he emigrated to Australia and was reviewed by an ear, nose and throat surgeon. He was reviewed regularly over the next 12 months with continuing discharge from the ear. In November 2005, a modified mastoidectomy and reconstruction were performed. Histopathology revealed granulation tissue, scar tissue and adipose tissue with fat necrosis and a mixed heavy acute and chronic inflammatory infiltrate with foci of acute suppurative inflammation.
A swab was sent to the Microbiology Department for routine microbiological analysis. Horse blood agar (HBA; Oxoid), MacConkey agar (MA; Oxoid) and chocolate agar (CHA; Oxoid) were inoculated and incubated for 48 h at 35 u C under 5 % CO 2 atmospheric conditions. A Sabouraud agar plate (Oxoid) was also inoculated and incubated at 30 u C in air for 7 days. A Gram stain was performed; this showed numerous polymorphs and predominant Gramnegative rods. After 24 h incubation, HBA, MA and CHA cultures demonstrated heavy growth of a Gram-negative bacillus. The Gram-negative bacillus was unable to be identified by routine laboratory protocols using standard biochemical reactions. An API 20NE (bioMérieux) was inoculated according to the manufacturer's recommendations and after 48 h incubation gave a profile number of 1000427 and an identification of Alcaligenes denitrificans with 88.6 % probability and an 'acceptable identification' confidence level. The isolate was also analysed on a VITEK 2 Compact (bioMérieux). The bionumber obtained was 4000001101500200, giving an identification of Pseudomonas fluorescens with 97 % probability and an 'excellent identification' confidence level. Analysis of whole-cell long-chain fatty acids was performed using the Microbial Identification System (MIS; MIDI). The MIS identified this isolate as Achromobacter xylosoxidans subsp. dentrificans with a similarity index (SI) of 0.658. An SI index of 0.5 or greater is considered correct to the species level. Due to discrepancies between these identification systems, sequence analysis was performed on the isolate.
MICs were determined using the VITEK 2 Compact (bioMérieux). Susceptibility profiles are shown in Table 1 .
The GenBank/EMBL/DDBJ accession numbers for the sequences described in this paper are EF212440, EF368181 and EF368182. Genomic DNA was extracted using a QIAamp DNA Mini kit (QIAGEN) and DNA amplification of the small-subunit rRNA gene was performed using universal primers as previously described by Fry et al. (2005) . Amplification of the genes for the Bordetella outer-membrane protein A (ompA) and the RisA response regulator (risA) was undertaken according to the method of von Wintzingerode et al. (2001) . The PCR products were purified using the QIAquick PCR Purification kit (QIAGEN) according to the manufacturer's instructions. The PCR products were sequenced in both directions on an ABI Prism 3730 automated sequencer at the SUPAMAC facility (Royal Prince Alfred Hospital, Sydney). The sequences generated were compared to those available in the GenBank databases using the BLASTN program run on the National Center for Biotechnology Information server (http://www.ncbi.nlm. nih.gov/blast/).
The sequence data generated from the three different gene loci provided a conclusive identification of Bordetella petrii.
The 16S rRNA gene sequence demonstrated 100 % homology with the 16S rRNA gene sequence of the first reported clinical isolate of B. petrii, the GDH030510 strain (GenBank accession no. AJ870969) (Fry et al., 2005) . The next highest homology of 99 % was with the prototype environmental isolate, the DSM 12804 T strain of B. petrii (GenBank accession no. AJ249861) (von Wintzingerode et al., 2001) . The risA and the ompA gene sequences demonstrated 100 % homology with both the risA and the ompA gene sequences of the GDH030510 strain of B. petrii (GenBank accession nos AJ920265 and AJ920264, respectively).
Discussion
The family Alcaligenaceae comprises the genera Bordetella and Alcaligenes and based on phenotypic and genotypic data also includes the genus Achromobacter (Yabuuchi et al., 1998) . The genus Bordetella currently consists of nine species. Bordetella pertussis is the aetiological agent of whooping cough (Hewlett, 1995) . Bordetella parapertussis causes a milder respiratory infection in humans and is also a causative agent of chronic pneumonia in sheep (Hewlett, 1995) . Bordetella holmesii has been isolated on a number of occasions from blood and sputum of humans (Weyant et al., 1995; Tang et al., 1998; Mazengia et al., 2000) . Bordetella trematum has been shown to cause both ear and wound infections exclusively in humans . Bordetella 'ansorpii' was identified recently when it was isolated from the purulent exudate of a patient with an epidermal cyst (Ko et al., 2005) . Bordetella bronchiseptica causes respiratory tract infections in many mammals and only rarely infects humans (Woolfrey & Moody, 1991; Gueirard et al., 1994) . Bordetella hinzii has been isolated from immunocompromised human hosts, but is mainly a commensal of the respiratory tract of poultry (Cookson et al., 1994; Vandamme et al., 1995; Funke et al., 1996) . Bordetella avium, a bird pathogen, is the only Bordetella species that has never been found in humans (Arp & Cheville, 1984) . B. petrii was first isolated and identified from an environmental source (von Wintzingerode et al., 2001) . There has only been one previously reported clinical case of B. petrii infection causing mandibular osteomyelitis (Fry et al., 2005) .
The sequence data generated from the 16S rRNA, risA and ompA genes definitively identified the isolate as B. petrii. The isolate was more closely related to the previously reported clinical isolate described by Fry et al. (2005) from London than to the type strain environmental isolate (von Wintzingerode et al., 2001) . Our isolate demonstrated 100 % homology with the 16S rRNA, risA and ompA genes of the first clinical isolate (Fry et al., 2005) and 99 % homology (reflecting a 12 bp difference) with the 16S rRNA gene of the B. petrii prototype strain, DSM 12804 T . There were some phenotypic differences between our isolate and the other reported B. petrii strains, DSM 12804 T and GDH030510. Our isolate failed to grow under anaerobic conditions and demonstrated motility whilst both other strains were facultatively anaerobic and non-motile. The Australian B. petrii strain assimilated phenylacetate but not malate, while the environmental DSM 12804
T strain did not assimilate phenylacetate but did assimilate malate.
The patient was treated with clarithromycin 500 mg b.d. for a period of 2 months. At follow-up appointments after antimicrobial drug therapy had ceased, clinical findings were normal with no signs of infection, and with significant improvement in hearing reported by the patient. The successful clinical outcome highlights the positive response to antimicrobial treatment.
The source of infection is unknown, but as B. petrii has been isolated from river sediment (von Wintzingerode et al., 2001) , it is likely that the isolate originated from an environmental source, possibly in Bangladesh given the patient's history of residence in that country. The pathogenesis of B. petrii is currently unknown. The characterization and identification of this clinical isolate may aid in the understanding and elucidation of the pathogenic potential of this unique member of the genus Bordetella.
This report describes the second clinical isolate of B. petrii worldwide and the first reported isolation of this organism from the mastoid and from a patient in Australia.
